Real-time collaboration platform for comprehensive live solutions
Concurrent editing creates those conflicts we all dread: reviewers work on outdated versions whilst progress stays invisible.
Ideagen Please Review transforms real-time collaboration—orchestrating smooth workflows across distributed teams where everyone works on the latest version with clear visibility.

Live collaboration solution with embedded intelligence
Ideagen Please Review enables teams from 2 to 200+ reviewers to collaborate concurrently without conflicts. The platform recognises workflows and eliminates friction points whilst maintaining detailed audit trails and version control.

Version conflicts from simultaneous editing creating document chaos
Multiple editors creating conflicting versions waste hours in resolution.
Ideagen Please Review prevents conflicts through smart synchronisation.
Lexicon Pharmaceuticals coordinates 20+ concurrent reviewers on regulatory documents—contributors work without overwriting changes. The platform coordinates contributions whilst maintaining document integrity. Focus on content, not conflict resolution.

Reviewers working on outdated document versions causing approval delays
When stakeholders review version 3 whilst version 5 awaits approval, cycles restart unnecessarily.
Ideagen Please Review ensures reviewers access latest versions.
BAE Systems reduced their post-review process from 24 hours to 30 minutes. Notifications alert when documents update. Workflow orchestration routes documents to next approval stage without manual intervention.

Lack of transparency in review progress frustrating stakeholders and project teams
Not knowing where documents sit or who needs to act creates unnecessary friction.
Ideagen Please Review provides clear visibility through progress tracking.
AAR Corp transformed proposal management—dashboards show exactly where documents are and who needs to act. Real-time status across all collaborative activities prevents bottlenecks.

See Ideagen Please Review in action
Access your personalized demo below.
Request a demo today
Additional reading

Why biotech leaders can’t afford delays in document review: The hidden risk to market access
Read more